News

The FDA and NIH are following through on commitments made in 2025 to begin phasing out cruel animal tests by revealing major initiatives toward that goal.

In a landmark move, the Oregon Health & Science University (OHSU) board voted on Monday, February 9 to negotiate with the NIH to potentially transform the Oregon National Primate Research Center into an animal sanctuary, radically transforming the lives of the 5,000 monkeys currently held there.

Last week CAARE sent a strong letter to University of Georgia (UGA) pressing them to create a clear and concrete plan to phase out animal experiments and move toward humane, modern, non-animal alternatives.

In a groundbreaking announcement Tuesday, April 29, 2025, the National Institutes of Health (NIH) revealed a new initiative to reduce animal experiments while expanding human-based science. The initiative comes less than three weeks after an announcement from the U.S. Food and Drug Administration (FDA) that it is implementing a phase-out plan for animal testing in drug development.

Last week the U.S. Food and Drug Administration (FDA) issued a groundbreaking announcement that it will start to phase out some animal testing requirements with the goal of eventually moving towards using animal-free models for all new drug approval — their most significant statement on this topic to date.

A prevailing myth is that even if animal experiments are problematic at the cellular or genetic level, we can learn something from them using the basic biomechanics of physiology. But this also has proven false. A recent study on anatomical predictions of muscle measurements based on experiments in mice showed that these are incorrect and can adversely impact surgical procedures on humans.

In a huge acknowledgement that we need to move away from animal research, Swiss company Roche, the fifth-largest pharmaceutical company in the world, has just launched an Institute for Human Biology to focus on human model systems that more precisely simulate human disease than animal experiments.

CAARE is thrilled to announce that the FDA Modernization Act 2.0 has been passed today, December 23, 2022, by the U.S. Congress!

We’re having a National call-in day on Tuesday, November 1st to urge Congress to support the FDA Modernization Act, and we need your help!

Yesterday, September 29, 2022, the Senate voted unanimously to pass the bipartisan FDA Modernization Act that would lift the absolute requirement for animal testing in new drug development.